IL128532A0 - Method of treating impotence due to spinal cord injury - Google Patents

Method of treating impotence due to spinal cord injury

Info

Publication number
IL128532A0
IL128532A0 IL12853299A IL12853299A IL128532A0 IL 128532 A0 IL128532 A0 IL 128532A0 IL 12853299 A IL12853299 A IL 12853299A IL 12853299 A IL12853299 A IL 12853299A IL 128532 A0 IL128532 A0 IL 128532A0
Authority
IL
Israel
Prior art keywords
spinal cord
cord injury
impotence due
treating impotence
male
Prior art date
Application number
IL12853299A
Other languages
English (en)
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of IL128532A0 publication Critical patent/IL128532A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Electrotherapy Devices (AREA)
IL12853299A 1998-02-23 1999-02-15 Method of treating impotence due to spinal cord injury IL128532A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7558098P 1998-02-23 1998-02-23

Publications (1)

Publication Number Publication Date
IL128532A0 true IL128532A0 (en) 2000-01-31

Family

ID=22126701

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12853299A IL128532A0 (en) 1998-02-23 1999-02-15 Method of treating impotence due to spinal cord injury

Country Status (17)

Country Link
US (1) US20060040935A1 (de)
EP (1) EP0951908B1 (de)
JP (1) JPH11315025A (de)
KR (1) KR19990072798A (de)
AT (1) ATE279194T1 (de)
AU (1) AU755402B2 (de)
CA (1) CA2262268C (de)
DE (1) DE69921008T2 (de)
DK (1) DK0951908T3 (de)
ES (1) ES2226281T3 (de)
HU (1) HUP9900438A3 (de)
IL (1) IL128532A0 (de)
MY (1) MY133446A (de)
NZ (1) NZ334333A (de)
PT (1) PT951908E (de)
TW (1) TW542719B (de)
ZA (1) ZA991393B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6548490B1 (en) 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
GT199900061A (es) * 1998-05-15 2000-10-14 Pfizer Formulaciones farmaceuticas.
US6200591B1 (en) * 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
DE19834506A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Transmucosales therapeutisches System zur Anwendung von Sildenafil
DE19834507A1 (de) * 1998-07-31 2000-02-03 Hexal Ag Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil
EP1173167A4 (de) 1999-04-30 2004-07-14 Lilly Icos Llc Behandlung der störungen der weiblichen erregbarkeit
EP1244673A2 (de) 1999-12-24 2002-10-02 Bayer Aktiengesellschaft Imidazo[1,3,5]triazinone und ihre verwendung
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
KR100393160B1 (ko) * 2001-06-14 2003-07-31 한국과학기술연구원 신규한 피라졸로피리미딘티온 유도체, 그의 제법 및발기부전 치료제로서의 용도
WO2002102385A1 (en) * 2001-06-14 2002-12-27 Sampad Bhattacharya Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis
CN101027061B (zh) 2004-05-11 2014-03-12 情感智能有限责任公司 药物制剂及其在治疗女性性功能障碍中的应用
EP1790343A1 (de) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmazeutische Zusammensetzungen und deren Verwendung zur Behandlung sexueller Störungen der Frau
EP1925307A1 (de) 2006-11-03 2008-05-28 Emotional Brain B.V. Verwendung von 3-alpha-androstanediol zur Behandlung sexueller Dysfunktion
WO2008142396A1 (en) * 2007-05-18 2008-11-27 Anthony Denis Maher Methods of assessing male fertility using a uridine marker

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114760D0 (en) * 1991-07-09 1991-08-28 Pfizer Ltd Therapeutic agents
GB9301192D0 (en) * 1993-06-09 1993-06-09 Trott Francis W Flower shaped mechanised table
GB9423911D0 (en) * 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
DK0951908T3 (da) 2004-12-27
PT951908E (pt) 2005-01-31
HU9900438D0 (en) 1999-04-28
CA2262268C (en) 2003-07-29
MY133446A (en) 2007-11-30
ES2226281T3 (es) 2005-03-16
TW542719B (en) 2003-07-21
JPH11315025A (ja) 1999-11-16
EP0951908A3 (de) 2000-08-16
HUP9900438A2 (hu) 2000-03-28
US20060040935A1 (en) 2006-02-23
CA2262268A1 (en) 1999-08-23
DE69921008D1 (de) 2004-11-18
ZA991393B (en) 2000-08-22
KR19990072798A (ko) 1999-09-27
AU1839099A (en) 1999-09-09
ATE279194T1 (de) 2004-10-15
NZ334333A (en) 2000-11-24
AU755402B2 (en) 2002-12-12
HUP9900438A3 (en) 2002-01-28
EP0951908A2 (de) 1999-10-27
EP0951908B1 (de) 2004-10-13
DE69921008T2 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
ZA991393B (en) Method of treating impotence due to spinal cord injury.
MY117967A (en) Intranasal formulations for treating sexual disorders
ZA200206612B (en) Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction.
EP1005336A4 (de) Verbesserte verfahren und zusammensetzungen zur behandlung männlicher erektionsstörungen
IL153492A0 (en) Treatment of male sexual dysfunction
WO1994004120A3 (en) Methods of treating sexual dysfunction in animals with and h agonist
PL343794A1 (en) Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
NZ270871A (en) Method for treating erectile dysfunction
ZA914135B (en) Method of treating impotence
BG105664A (en) Use of apomophines for the treatment of organic erectile dysfunction in males
AU2001250821A1 (en) Methods and compositions for the treatment and prevention of erectile dysfunction
EP1108426A3 (de) Anwendung von Prostaglandinagonisten zur Behandlung der Erektionstörungen und Impotenz
ID24184A (id) Obat untuk perawatan disfungsi ereksi
AU2623700A (en) Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
WO2000053148A3 (en) Methods and compositions for treating erectile dysfunction
IL155775A0 (en) Treatment of male sexual dysfunction
WO2005051368A3 (en) Phosphodiesterase v inhibitor formulations
MD1979F1 (en) Method of secondary cataract treatment
AU8906201A (en) Methods and compositions for the treatment and prevention of sexual dysfunction
WO1996036339A3 (en) Use of dihydrotestosterone compounds for treating male sexual dysfunction
IL166273A0 (en) Methods of treatment of male erectile dysfunction
ZA923961B (en) Use of atipamezole
AU2001281396A1 (en) Novel compositions and methods for treatment of male erectile dysfunction
GB9928178D0 (en) Agent for the treatment of male and female sexual dysfunction
CA2203379A1 (en) Cgmp-pde inhibitors for the treatment of erectile dysfunction

Legal Events

Date Code Title Description
HP Change in proprietorship